Brian Lian
Also at Viking Therapeutics Inc
About
Brian Lian, Ph.D., has an extensive academic background that includes degrees in chemistry and finance, providing him with a solid foundation in both scientific research and financial analysis.
He began his career in biotechnology as a research scientist at firms such as Amgen and Microcide Pharmaceuticals before transitioning into financial services where he held senior roles at institutions including CIBC World Markets, The Agave Group, Global Hunter Securities, and SunTrust Robinson Humphrey.
Since September 2012, he has served as President and CEO of VKTX, leading the company with over 15 years of experience in both biotechnology and financial services. His role has been complemented by board participation at Seelos Therapeutics, further demonstrating his broad expertise in the industry.